Correction: Benzoflavone derivatives as potent antihyperuricemic agents(MedChemCommun (2019) DOI: 10.1039/c8md00512e)

Jatinder V. Singh; Gurbachan Mal; Gurleen Kaur; Manish K. Gupta; Amrit Pal Singh; Kunal Nepali; Harbinder Singh; Sahil Sharma; Preet Mohinder S. Bedi

doi:10.1039/C9MD90002K

Correction: Benzoflavone derivatives as potent antihyperuricemic agents(MedChemCommun (2019) DOI: 10.1039/c8md00512e)

Jatinder V. Singh, Gurbachan Mal, Gurleen Kaur, Manish K. Gupta, Amrit Pal Singh, Kunal Nepali, Harbinder Singh, Sahil Sharma, Preet Mohinder S. Bedi

研究成果: 雜誌貢獻 › 評論/辯論

1 引文斯高帕斯（Scopus）

摘要

The authors regret that the name of one of the authors, Amrit Pal Singh, is displayed incorrectly on their manuscript. The corrected list of authors for this paper is as shown above. The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.

原文	英語
頁數	1
期刊	MedChemComm
卷	10
發行號	1
DOIs	https://doi.org/10.1039/C9MD90002K
出版狀態	已發佈 - 一月 1 2019
對外發佈	Yes

ASJC Scopus subject areas

Biochemistry
Molecular Medicine
Pharmacology
Pharmaceutical Science
Drug Discovery
Organic Chemistry

存取文件

10.1039/C9MD90002K

指紋深入研究「Correction: Benzoflavone derivatives as potent antihyperuricemic agents(MedChemCommun (2019) DOI: 10.1039/c8md00512e)」主題。共同形成了獨特的指紋。

引用此

Singh, J. V., Mal, G., Kaur, G., Gupta, M. K., Singh, A. P., Nepali, K., Singh, H., Sharma, S., & Bedi, P. M. S. (2019). Correction: Benzoflavone derivatives as potent antihyperuricemic agents(MedChemCommun (2019) DOI: 10.1039/c8md00512e). MedChemComm, 10(1). https://doi.org/10.1039/C9MD90002K

Correction : Benzoflavone derivatives as potent antihyperuricemic agents(MedChemCommun (2019) DOI: 10.1039/c8md00512e). / Singh, Jatinder V.; Mal, Gurbachan; Kaur, Gurleen; Gupta, Manish K.; Singh, Amrit Pal; Nepali, Kunal; Singh, Harbinder; Sharma, Sahil; Bedi, Preet Mohinder S.

於: MedChemComm, 卷 10, 編號 1, 01.01.2019.

研究成果: 雜誌貢獻 › 評論/辯論

@article{436b843800424bc0a5acc9352653a0cd,

title = "Correction: Benzoflavone derivatives as potent antihyperuricemic agents(MedChemCommun (2019) DOI: 10.1039/c8md00512e)",

abstract = "The authors regret that the name of one of the authors, Amrit Pal Singh, is displayed incorrectly on their manuscript. The corrected list of authors for this paper is as shown above. The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.",

author = "Singh, {Jatinder V.} and Gurbachan Mal and Gurleen Kaur and Gupta, {Manish K.} and Singh, {Amrit Pal} and Kunal Nepali and Harbinder Singh and Sahil Sharma and Bedi, {Preet Mohinder S.}",

year = "2019",

month = jan,

day = "1",

doi = "10.1039/C9MD90002K",

language = "English",

volume = "10",

journal = "MedChemComm",

issn = "2040-2503",

publisher = "Royal Society of Chemistry",

number = "1",

}

TY - JOUR

T1 - Correction

T2 - Benzoflavone derivatives as potent antihyperuricemic agents(MedChemCommun (2019) DOI: 10.1039/c8md00512e)

AU - Singh, Jatinder V.

AU - Mal, Gurbachan

AU - Kaur, Gurleen

AU - Gupta, Manish K.

AU - Singh, Amrit Pal

AU - Nepali, Kunal

AU - Singh, Harbinder

AU - Sharma, Sahil

AU - Bedi, Preet Mohinder S.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The authors regret that the name of one of the authors, Amrit Pal Singh, is displayed incorrectly on their manuscript. The corrected list of authors for this paper is as shown above. The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.

AB - The authors regret that the name of one of the authors, Amrit Pal Singh, is displayed incorrectly on their manuscript. The corrected list of authors for this paper is as shown above. The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.

UR - http://www.scopus.com/inward/record.url?scp=85060495943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060495943&partnerID=8YFLogxK

U2 - 10.1039/C9MD90002K

DO - 10.1039/C9MD90002K

M3 - Comment/debate

AN - SCOPUS:85060495943

VL - 10

JO - MedChemComm

JF - MedChemComm

SN - 2040-2503

IS - 1

ER -